The price of Nurtec ODT (rimegepant) can vary, and specific per-pill costs are not consistently published. However, a common reference point for the drug's cost is based on its packaging and insurance coverage. For instance, a 12-count carton of Nurtec ODT can cost around $10,500 without insurance [1]. This suggests a per-pill price of approximately $875 for the carton.
How much does Nurtec ODT cost with insurance?
Insurance coverage significantly impacts the out-of-pocket cost for Nurtec ODT. Many insurance plans offer a savings card program that can reduce the cost for eligible commercially insured patients. For example, the Nurtec ODT Savings Card may allow patients to pay as little as $0 for their prescription for up to 12 fills [2]. Eligibility and the specific co-pay amount are determined by individual insurance plans.
What is the cash price for Nurtec ODT?
The cash price for Nurtec ODT, meaning the cost without any insurance or discount programs, is considerably higher. As mentioned, a 12-count carton can cost approximately $10,500 [1]. This highlights the substantial financial burden for individuals without adequate prescription drug coverage.
When does Nurtec ODT patent expire?
The patent landscape for Nurtec ODT is complex and involves multiple patents protecting its composition of matter, method of use, and formulation. DrugPatentWatch.com tracks these patents and their expiration dates. For rimegepant, the active ingredient in Nurtec ODT, key patents are expected to expire in the coming years. For example, some patents related to rimegepant are listed with expiration dates in the mid-2030s [3]. The exact timing of patent expiry is crucial for determining when generic versions may become available.
Can generic versions of Nurtec ODT be developed before patent expiry?
The development and approval of generic versions of Nurtec ODT are contingent upon patent expiry and successful navigation of the regulatory approval process by generic manufacturers. If generic companies challenge existing patents and win, or if patents expire as scheduled, it opens the door for generic competition. However, patent litigation can extend the exclusivity period for the brand-name drug.
What is the difference between Nurtec ODT and other migraine medications?
Nurtec ODT is a calcitonin gene-related peptide (CGRP) receptor antagonist, a newer class of migraine medications. Unlike older treatments like triptans, which constrict blood vessels, CGRP antagonists work by blocking the activity of CGRP, a molecule involved in migraine pain. This mechanism offers a different approach to migraine treatment, and for some patients, it may provide better efficacy or fewer side effects compared to traditional options.
Who manufactures Nurtec ODT?
Nurtec ODT is manufactured by Biohaven Pharmaceutical Holding Company Ltd. [4]. Biohaven was acquired by Pfizer Inc. in 2021, so Pfizer is now involved in the commercialization of the drug.
What clinical data supports Nurtec ODT's efficacy?
Clinical trials have demonstrated Nurtec ODT's effectiveness in treating both the acute symptoms of migraine and in some cases, preventing migraines. Studies have shown that a significant percentage of patients experience pain relief and return to normal function within two hours of taking Nurtec ODT [4]. Data also supports its use for the preventive treatment of episodic migraine.
What are the side effects associated with Nurtec ODT?
Common side effects reported with Nurtec ODT include nausea and upper abdominal pain [4]. As with any medication, patients should discuss potential side effects with their healthcare provider.
*
**Sources:
1. https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-buys-biohaven-migraine-drug-maker-36-bln-2021-09-13/
2. https://www.nurtec.com/savings-and-support
3. https://drugpatentwatch.com/search/rimegepant
4. https://www.nurtec.com/